Search Within

Matthew David Hellmann

  1. "Computational Oncology Service"
Formats
  1. Journal Article (20)
  2. Meeting Abstract (6)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (26)
  2. Computational Oncology Service (26)
  3. Department of Medicine (26)
  4. Epidemiology and Biostatistics (26)
  5. GSK Faculty (26)
  6. Solid Tumor Oncology Division (26)

More Groups

People
  1. Hira Rizvi (17)
  2. Charles Rudin (12)
  3. Gregory Riely (12)
  4. Nikolaus Schultz (12)
  5. Marc Ladanyi (10)
  6. Francisco Sanchez Vega (9)

More People

Years
  1. 2024 (1)
  2. 2022 (9)
  3. 2021 (1)
  4. 2020 (3)
  5. 2019 (3)
  6. 2018 (6)

More Years

Publications
  1. Clinical Cancer Research (4)
  2. Journal of Clinical Oncology (4)
  3. Cancer Cell (3)
  4. Annals of Oncology (2)
  5. Cancer Discovery (2)
  6. JCO Precision Oncology (2)

More Publications

Publishers
  1. American Association for Cancer Research (6)
  2. American Society of Clinical Oncology (6)
  3. Cell Press (3)
  4. Nature Publishing Group (3)
  5. Nature Research (2)
  6. Oxford University Press (2)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tim-4(+) cavity-resident macrophages impair anti-tumor CD8(+) T cell immunity
    Journal Article

    Chow, A.; Schad, S.; Green, M. D.; Hellmann, M. D.; Allaj, V.; Ceglia, N.; Zago, G.; Shah, N. S.; Sharma, S. K.; Mattar, M.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine
    Meeting Abstract

    Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • COVID-19 in patients with lung cancers in New York City
    Meeting Abstract

    Luo, J.; Rizvi, H.; Preeshagul, I. R.; Egger, J. V.; Hoyos, D.; Bandlamudi, C.; Donoghue, M. T. A.; Łuksza, M.; Greenbaum, B. D.; Wolchok, J. D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • COVID-19 in patients with lung cancer
    Journal Article

    Luo, J.; Rizvi, H.; Preeshagul, I. R.; Egger, J. V.; Hoyos, D.; Bandlamudi, C.; McCarthy, C. G.; Falcon, C. J.; Schoenfeld, A. J.; Arbour, K. C.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Harmonization of tumor mutational burden quantification and association with response to immune checkpoint blockade in non-small-cell lung cancer
    Journal Article

    Vokes, N. I.; Liu, D.; Ricciuti, B.; Jimenez-Aguilar, E.; Rizvi, H.; Dietlein, F.; He, M. X.; Margolis, C. A.; Elmarakeby, H. A.; Girshman, J.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
    Journal Article

    Hastings, K.; Yu, H. A.; Wei, W.; Sanchez-Vega, F.; DeVeaux, M.; Choi, J.; Rizvi, H.; Lisberg, A.; Truini, A.; Lydon, C. A.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Tumor mutation burden and efficacy of EGFR-tyrosine kinase inhibitors in patients with EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez-Vega, F.; Li, B. T.; Drilon, A.; Kris, M. G.; Rudin, C. M.; Schultz, N.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC
    Meeting Abstract

    Rizvi, H.; Plodkowski, A. J.; Tenet, M.; Halpenny, D.; Long, N.; Sauter, J. L.; Sanchez-Vega, F.; Chatila, W. K.; Schultz, N.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor mutation burden and efficacy of targeted therapy in patients with EGFR mutant lung cancers
    Meeting Abstract

    Offin, M. D.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez Vega, F.; Kris, M. G.; Rudin, C. M.; Riely, G. J.; Yu, H. A.; Hellmann, M. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Concurrent mutations in STK11 and KEAP1 is associated with resistance to PD-(L)1 blockade in patients with NSCLC despite high TMB
    Meeting Abstract

    Arbour, K.; Shen, R.; Plodkowski, A.; Rizvi, H.; Ni, A.; Long, N.; Halpenny, D.; Sanchez-Vega, F.; Rudin, C.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save